- Home
- BPRN vs APLT Comparison
BPRN vs APLT Comparison
Compare BPRN & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPRN
- APLT
- Stock Information
- Founded
- BPRN 2007
- APLT 2016
- Country
- BPRN United States
- APLT United States
- Employees
- BPRN N/A
- APLT N/A
- Industry
- BPRN Major Banks
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- BPRN Finance
- APLT Health Care
- Exchange
- BPRN Nasdaq
- APLT Nasdaq
- Market Cap
- BPRN 220.5M
- APLT 178.6M
- IPO Year
- BPRN N/A
- APLT 2019
- Fundamental
- Price
- BPRN $33.75
- APLT $0.26
- Analyst Decision
- BPRN Strong Buy
- APLT Buy
- Analyst Count
- BPRN 1
- APLT 5
- Target Price
- BPRN $35.00
- APLT $4.13
- AVG Volume (30 Days)
- BPRN 9.5K
- APLT 25.3M
- Earning Date
- BPRN 10-29-2025
- APLT 11-13-2025
- Dividend Yield
- BPRN 4.06%
- APLT N/A
- EPS Growth
- BPRN 62.30
- APLT N/A
- EPS
- BPRN 2.57
- APLT N/A
- Revenue
- BPRN $76,577,000.00
- APLT $1,000,000.00
- Revenue This Year
- BPRN $14.10
- APLT N/A
- Revenue Next Year
- BPRN $8.94
- APLT $5,935.35
- P/E Ratio
- BPRN $13.41
- APLT N/A
- Revenue Growth
- BPRN 13.94
- APLT N/A
- 52 Week Low
- BPRN $27.25
- APLT $0.22
- 52 Week High
- BPRN $38.78
- APLT $10.48
- Technical
- Relative Strength Index (RSI)
- BPRN 70.31
- APLT 28.24
- Support Level
- BPRN $31.71
- APLT $0.25
- Resistance Level
- BPRN $33.95
- APLT $0.40
- Average True Range (ATR)
- BPRN 0.72
- APLT 0.10
- MACD
- BPRN 0.14
- APLT -0.04
- Stochastic Oscillator
- BPRN 100.00
- APLT 5.13
About BPRN Princeton Bancorp Inc. (PA)
Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.